NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  



NIH Main


NIH Research News


Funded News

  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
  Additional Resources
  NIH Home Page

About NIH

  NIH Health Information
  Pub Med
  More News and Events Sources
  NIH News and Events, Special Interest
  RSS Feed RSS Feed
  Back to EurekAlert!


Department of Health and Human Services

News from the National Institutes of Health

Funded News

Key: Meeting M      Journal J      Funder F

Showing releases 2876-2900 out of 3686.

<< < 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 > >>

Public Release: 20-Feb-2015
Alcoholism: Clinical & Experimental Research
Alcohol places Hispanics at a much greater risk of developing alcoholic liver disease
Alcoholic liver disease is a common liver ailment in the US that varies significantly by ethnicity. A new study looks the role of ethnicity in the age of onset, severity, and risk factors for progression of ALD. Results indicate that ethnicity is a major factor affecting the age and severity of different subtypes of ALD.
National Center for Advancing Translational Sciences, National Institutes of Health, Division of Gastroenterology and Hepatology at UC Davis

Contact: Karen Finney
Alcoholism: Clinical & Experimental Research

Public Release: 19-Feb-2015
New target for prostate cancer treatment discovered by Keck Medicine of USC researchers
Keck Medicine of the University of Southern California scientists have found a promising new therapeutic target for prostate cancer. The findings offer evidence that a newly discovered member of a family of cell surface proteins called G-protein coupled receptors promotes prostate cancer cell growth.
National Institutes of Health, Robert E. and May R. Wright Foundation

Contact: Leslie Ridgeway
University of Southern California - Health Sciences

Public Release: 19-Feb-2015
New England Journal of Medicine
Johns Hopkins Helps to lead discovery on efficacy and safety of 3 drugs for treating DME
A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs -- Eylea, Avastin and Lucentis -- used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.
National Eye Institute, part of the National Institutes of Health

Contact: Marin Hedin
Johns Hopkins Medicine

Public Release: 19-Feb-2015
Nature Communications
Penn researchers develop new technique for making molybdenum disulfide
University of Pennsylvania researchers have made an advance in manufacturing molybdenum disulphide, a 2-D material that could compete with graphene for replacing silicon in next-generation electronics. By growing flakes of the material around 'seeds' of molybdenum oxide, they have made it easier to control the size, thickness and location of the material.
National Science Foundation, National Institutes of Health, US Army Research Office

Contact: Evan Lerner
University of Pennsylvania

Public Release: 19-Feb-2015
Nature Communications
New nanogel for drug delivery
MIT chemical engineers have designed a new type of self-healing hydrogel that could be injected through a syringe.
Wellcome Trust, isrock Foundation, Department of Defense, National Institutes of Health

Contact: Sarah McDonnnell
Massachusetts Institute of Technology

Public Release: 19-Feb-2015
Evolution may hold the key to more designer cancer drugs like Gleevec
Dorothee Kern, a professor of biochemistry and Howard Hughes Medical Institute investigator, unraveled the journey of two closely related cancer-causing proteins -- one susceptible to the drug Gleevec and one not -- over one billion years of evolution. She and her team pinpointed the exact evolutionary shifts that caused Gleevec to bind well with one and poorly with the other. This new approach may have a major impact on the development of rational drugs to fight cancer.
Howard Hughes Medical Institute, Office of Basic Energy Sciences, Catalysis Science Program, US Department of Energy, National Institutes of Health

Contact: Leah Burrows
Brandeis University

Public Release: 19-Feb-2015
Precision medicine to prevent diabetes? Personalized model could steer prevention efforts
Researchers have just released a 'precision medicine' approach to diabetes prevention that could keep more people from joining the ranks of the 29 million Americans with diabetes -- using existing information like blood sugar levels and waist-to-hip ratios, and without needing new genetic tests.
Patient-Centered Outcomes Research Institute, NIH/National Institute of Neurological Disorders and Stroke, Department of Veterans Affairs Quality Enhancement Research Initiative, National Institute of Diabetes and Digestive and Kidney Diseases

Contact: Kara Gavin
University of Michigan Health System

Public Release: 19-Feb-2015
New England Journal of Medicine
UW research shows sensor technology may help improve accuracy of clinical breast exams
Sensor technology has the potential to significantly improve the teaching of proper technique for clinical breast exams, according to a new study by researchers at the University of Wisconsin School of Medicine and Public Health.
National Institutes of Health

Contact: Gian Galassi
University of Wisconsin-Madison

Public Release: 19-Feb-2015
Molecular Autism
Growth hormone improves social impairments in those with autism-linked disorder
A growth hormone can significantly improve the social impairment associated with autism spectrum disorder in patients with a related genetic syndrome.
Beatrice and Samuel A. Seaver Foundation, NIH/National Institute of Mental Health

Contact: Elizabeth Dowling
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 19-Feb-2015
Journal of Physiology
Researchers study role of hydrogen sulfide in regulating blood pressure
Widely considered simply a malodorous toxic gas, hydrogen sulfide is now being studied for its probable role in regulating blood pressure, according to researchers.
National Institutes of Health

Contact: A'ndrea Elyse Messer
Penn State

Public Release: 19-Feb-2015
IUPUI biologist receives NIH grant to study how glaucoma develops in stem cells
Jason Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University-Purdue University Indianapolis, has received a National Institutes of Health grant to study how glaucoma develops in stem cells created from skin cells genetically predisposed to the disease. The five-year, $1.8 million grant is funded by the NIH's National Eye Institute.
NIH/National Eye Institute

Contact: Candace Gwaltney
Indiana University-Purdue University Indianapolis School of Science

Public Release: 19-Feb-2015
Movement Disorders
Statins may not lower Parkinson's risk
The use of statins may not be associated with lowering risk for Parkinson's disease, according to a new study led by researchers at Penn State College of Medicine and National Institute of Environmental Health Sciences. The findings cast doubts on reports suggesting that the cholesterol-lowering medications may protect against this neurodegenerative brain disorder.
National Institutes of Health

Contact: Matt Solovey
Penn State

Public Release: 19-Feb-2015
New England Journal of Medicine
UW ophthalmologists help demonstrate effectiveness of diabetic macular edema treatments
An ophthalmology research team at the University of Wisconsin-Madison took part in a nationwide clinical trial comparing treatments for a form of diabetic eye disease. The study found that three commonly used drugs perform much the same for those with mild vision problems, but one medication performed better for those with more serious vision loss.
National Institutes of Health

Contact: Emily Kumlien
University of Wisconsin-Madison

Public Release: 19-Feb-2015
Journal for Nurse Practitioners
Mobile app with evidence-based decision support diagnoses more obesity, smoking, and depression, Columbia Nursing study finds
Smartphones and tablets may hold the key to getting more nurses to diagnose patients with chronic health issues like obesity, smoking, and depression -- three of the leading causes of preventable death and disability.
NIH/National Institute for Nursing Research

Contact: Lisa Rapaport
Columbia University Medical Center

Public Release: 19-Feb-2015
$8 million grant to fund Rat Genome Database at MCW
The Medical College of Wisconsin has received a four-year, $8 million grant from the National Institutes of Health's National Heart, Lung and Blood Institute to fund the Rat Genome Database, a unique, globally-accessible collection of data from ongoing rat genetic and genomic research efforts.
NIH/National Heart, Lung, and Blood Institute

Contact: Maureen Mack
Medical College of Wisconsin

Public Release: 19-Feb-2015
A dog lives on; now the stage is being set for treating humans
The National Cancer Institute has awarded Scott Verbridge, an assistant professor of biomedical engineering and mechanics at Virginia Tech, a $386,149 research grant to move a process that has been used in clinical trials a step closer to using on humans. Verbridge will lead a research team focusing on targeting and destroying the most therapy-resistant infiltrative cells in malignant glioma.
NIH/National Cancer Institute

Contact: Lynn Nystrom
Virginia Tech

Public Release: 19-Feb-2015
Current Biology
Proteins pull together as cells divide
Like a surgeon separating conjoined twins, cells have to be careful to get everything just right when they divide in two. Successful cell division hangs on the formation of a dip called a cleavage furrow, a process that has remained mysterious. Now, researchers at Johns Hopkins have found that no single molecular architect directs the cleavage furrow's formation; rather, it is a robust structure made of a suite of team players.
Hay Graduate Fellowship Fund, NIH/National Institute for General Medical Sciences, National Institutes of Health Office of the Director, Johns Hopkins Physical Sciences-Oncology Center

Contact: Shawna Williams
Johns Hopkins Medicine

Public Release: 19-Feb-2015
Nature Communications
New clues to causes of birth defects
Researchers at Albert Einstein College of Medicine of Yeshiva University have found a possible clue to why older mothers face a higher risk for having babies born with conditions such as Down syndrome that are characterized by abnormal chromosome numbers.
National Institutes of Health, 23andMe

Contact: Deirdre Branley
Albert Einstein College of Medicine

Public Release: 19-Feb-2015
Airport screening misses half of disease cases but could be improved
Researchers from the University of California Los Angeles and the London School of Hygiene and Tropical Medicine have found that in order to be effective, the screening of passengers for disease at airports must be tailored to the outbreak in question.
National Institutes of Health, Medical Research Council

Contact: Jennifer Mitchell

Public Release: 19-Feb-2015
New study helps explain links between sleep loss and diabetes
Lack of sleep can elevate levels of free fatty acids in the blood, accompanied by temporary pre-diabetic conditions in healthy young men. The finding adds to the evidence that insufficient sleep may disrupt fat metabolism and decrease insulin's effects. Getting enough sleep could help counteract the current epidemics of diabetes and obesity.
The National Institutes of Health, the Department of Defense, and Science in Society - Branco Weiss Fellowship.

Contact: John Easton
University of Chicago Medical Center

Public Release: 19-Feb-2015
Sunlight continues to damage skin in the dark
Much of the damage that ultraviolet radiation does to skin occurs hours after sun exposure, a team of Yale-led researchers concluded in a study that was published online Feb. 19 by the journal Science.
US Department of Defense, National Institutes of Health

Contact: Ziba Kashef
Yale University

Public Release: 19-Feb-2015
New ALS gene and signaling pathways identified
Using advanced DNA sequencing methods, researchers have identified a new gene that is associated with sporadic amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
Biogen Idec, Wellcome Trust, Medical Research Council, MND Association, American ALS Association, National Institutes of Health, Angel Fund, Project ALS/P2ALS, ALS Therapy Alliance, Pierre L. de Bourghknecht ALS Research Foundation, and others

Contact: Karin Eskenazi
Columbia University Medical Center

Public Release: 19-Feb-2015
Current Biology
Evolving a bigger brain with human DNA
The human brain expanded dramatically in size during evolution, imparting us with unique capabilities. Duke scientists have now shown that it's possible to pick out key changes in the genetic code between chimpanzees and humans and visualize their respective contributions to early brain development in mouse embryos. The findings may lend insight what makes the human brain special and why people get some neurological disorders, such as autism and Alzheimer's disease, whereas chimpanzees don't.
Duke Institute for Brain Sciences, National Institutes of Health, National Science Foundation

Contact: Karl Bates
Duke University

Public Release: 18-Feb-2015
Nature Communications
Bacterial defense mechanism targets duchenne muscular dystrophy
Researchers at Duke University have demonstrated a gene therapy technique that has the potential to treat more than half of the patients suffering from Duchenne Muscular Dystrophy by targeting a large region of the gene that contains many different mutations that cause the disease.
Muscular Dystrophy Association, Duke-Coulter Translational Partnership, The Hartwell Foundation, March of Dimes Foundation, National Institutes of Health

Contact: Ken Kingery
Duke University

Public Release: 18-Feb-2015
Infection and Immunity
Stalking a wily foe: Scientists figure out how C. difficile bacteria wreak havoc in guts
By staying up for two days straight, researchers have figured out for the first time exactly how Clostridium difficile wreaks havoc on the guts of animals in such a short time. The findings could help prevent or treat severe diarrhea and life-threatening disease in humans.
National Institutes of Health

Contact: Kara Gavin
University of Michigan Health System

Showing releases 2876-2900 out of 3686.

<< < 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 > >>


Copyright ©2015 by AAAS, the science society.